Ozempic and Wegovy linked to nearly 40% fewer asthma attacks
Semaglutide, the drug found in Ozempic and Wegovy, was linked to nearly 40% fewer asthma attacks in a large real-world study. It was also associated with about 20% fewer COPD flare-ups. Researchers say GLP-1 drugs may offer respiratory benefits in addition to their effects on diabetes and obesity, but clinical trials are needed to confirm the findings.
We haven't written up this one. ScienceDaily Health has the full story — the link below goes straight to it.
